(Total Views: 32)
Posted On: 08/22/2025 7:49:48 AM
Post# of 38876

$CVM CEL-SCI’s Multikine Head and Neck Cancer Immunotherapy Breakthrough Medicine Designation Filed in Saudi Arabia: Allows for Patient Access and Reimbursement/Sale Upon Granting of the Designation Which Takes Approximately 60 Days Based on SFDA Timeline
https://finance.yahoo.com/news/cel-sci-multik...00923.html

